# Laboratory Genetics * **Definition:** Laboratory Genetics is a branch of medical genetics that involves the analysis of genetic material (DNA, RNA, and chromosomes) in a laboratory setting to diagnose, monitor, and manage genetic disorders, as well as to inform treatment decisions and assess risk for inherited conditions. * **Taxonomy:** Specialties / Laboratory Genetics ## News * Selected news on the topic of **Laboratory Genetics**, for healthcare technology leaders * 3.9K news items are in the system for this topic * Posts have been filtered for tech-related keywords | Date | Title | Source | | --- | --- | --- | | 3/25/2025 | [**Health IT - Becker's Hospital Review**](https://www.beckershospitalreview.com/healthcare-information-technology/page/705/) | [[Beckers Hospital Review]] | | 3/19/2025 | [**Health IT & CIO Report Archives - Page 258 of 294 - Becker's Hospital Review**](https://www.beckershospitalreview.com/newsletter-category/beckers-hospital-cio-report-e-weekly/page/258/) | [[Beckers Hospital Review]] | | 3/7/2025 | [**The Future of Biotechnology: Medical, Food Technology, and Bioinformatics Innovations**](https://medium.com/@sourabh.more_60784/the-future-of-biotechnology-medical-food-technology-and-bioinformatics-innovations-37c067197fbb) | [[Medium]] | | 12/31/2024 | [**Precision Medicine Software Market Focused Insights 2024-2029, with Key Player Profiles of ...**](https://www.businesswire.com/news/home/20241231013633/en/Precision-Medicine-Software-Market-Focused-Insights-2024-2029-with-Key-Player-Profiles-of-Syapse-AccessDX-Laboratory-Fabric-Genomics-Foundation-Medicine-Intel-and-IBM---ResearchAndMarkets.com) | [[Business Wire]] | | 12/31/2024 | [**Precision Medicine Software Market Focused Insights 2024-2029, with Key Player Profiles of Syapse, AccessDX Laboratory, Fabric Genomics, Foundation Medicine, Intel and IBM - ResearchAndMarkets.com**](http://www.businesswire.com/news/home/20241231013633/en/Precision-Medicine-Software-Market-Focused-Insights-2024-2029-with-Key-Player-Profiles-of-Syapse-AccessDX-Laboratory-Fabric-Genomics-Foundation-Medicine-Intel-and-IBM---ResearchAndMarkets.com/?feedref=JjAwJuNHiystnCoBq_hl-Q-tiwWZwkcswR1UZtV7eGe24xL9TZOyQUMS3J72mJlQ7fxFuNFTHSunhvli30RlBNXya2izy9YOgHlBiZQk2LOzmn6JePCpHPCiYGaEx4DL1Rq8pNwkf3AarimpDzQGuQ==) | [[Business Wire]] | | 12/31/2024 | [**Precision Medicine Software Market Focused Insights 2024-2029, with Key Player Profiles of Syapse, AccessDX Laboratory, Fabric Genomics, Foundation Medicine, Intel and IBM - ResearchAndMarkets.com**](http://www.businesswire.com/news/home/20241231013633/en/Precision-Medicine-Software-Market-Focused-Insights-2024-2029-with-Key-Player-Profiles-of-Syapse-AccessDX-Laboratory-Fabric-Genomics-Foundation-Medicine-Intel-and-IBM---ResearchAndMarkets.com/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 12/30/2024 | [**Precision Medicine Software Research Analysis Report 2024-2030: Increasing Adoption of Genomic Data Analysis Software Spurs Growth, Integration of Multi-Omics Data Strengthens the Business Case - ResearchAndMarkets.com**](http://www.businesswire.com/news/home/20241230952002/en/Precision-Medicine-Software-Research-Analysis-Report-2024-2030-Increasing-Adoption-of-Genomic-Data-Analysis-Software-Spurs-Growth-Integration-of-Multi-Omics-Data-Strengthens-the-Business-Case---ResearchAndMarkets.com/?feedref=JjAwJuNHiystnCoBq_hl-Q-tiwWZwkcswR1UZtV7eGe24xL9TZOyQUMS3J72mJlQ7fxFuNFTHSunhvli30RlBNXya2izy9YOgHlBiZQk2LOzmn6JePCpHPCiYGaEx4DL1Rq8pNwkf3AarimpDzQGuQ==) | [[Business Wire]] | | 12/7/2024 | [**Genotyping Market to Hit USD 59.31 Billion by 2032 with 14.27AGR - Report by S&S Insider**](https://finance.yahoo.com/news/genotyping-market-hit-usd-59-140000786.html) | [[Yahoo Finance]] | | 11/27/2024 | [**Patient Engagement Technology Market to grow by USD 37.41 Billion from 2024-2028 ...**](https://www.prnewswire.com/news-releases/patient-engagement-technology-market-to-grow-by-usd-37-41-billion-from-2024-2028--driven-by-rising-chronic-disease-cases-and-ais-impact-on-market-trends---technavio-302316647.html) | [[PR Newswire]] | | 11/26/2024 | [**Mount Sinai leans into AI with new research center - Healthcare Finance News**](https://www.healthcarefinancenews.com/news/mount-sinai-leans-ai-new-research-center) | [[Healthcare Finance]] | | 11/26/2024 | [**Mount Sinai Center to Combine AI, Data Science, Genomics - Healthcare Innovation**](https://www.hcinnovationgroup.com/analytics-ai/artifical-intelligence-machine-learning/news/55246083/mount-sinai-center-to-combine-ai-data-science-genomics) | [[Healthcare Innovation]] | | 11/25/2024 | [**Mount Sinai Health announces new Center for AI and Human Health - Healthcare IT News**](https://www.healthcareitnews.com/news/mount-sinai-health-announces-new-center-ai-and-human-health) | [[Healthcare IT News]] | | 11/25/2024 | [**Digi-Tech Pharma & AI Conference 2025: AI and Genomics Take Center Stage (London ...**](https://www.marketwatch.com/press-release/digi-tech-pharma-ai-conference-2025-ai-and-genomics-take-center-stage-london-united-kingdom-may-28-29-2025-researchandmarkets-com-2a20b074) | [[MarketWatch]] | | 11/22/2024 | [**Market Trends Report: Analyzing the Mobile Medical Device Connectivity Market's ... - LinkedIn**](https://www.linkedin.com/pulse/market-trends-report-analyzing-mobile-medical-device-w9qqe) | [[Linkedin]] | | 11/15/2024 | [**Whole Genome and Exome Sequencing Markets, 2033 - ResearchAndMarkets.com**](http://www.businesswire.com/news/home/20241115785002/en/Whole-Genome-and-Exome-Sequencing-Markets-2033---ResearchAndMarkets.com/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 11/11/2024 | [**Population Health Management Market to Grow by USD 22.55 Billion from 2024-2028 ...**](https://www.prnewswire.com/news-releases/population-health-management-market-to-grow-by-usd-22-55-billion-from-2024-2028--driven-by-rising-adoption-of-healthcare-it-report-with-ai-impact-on-trends---technavio-302300769.html) | [[PR Newswire]] | | 11/8/2024 | [**AI-driven precision healthcare is here - what you need to know**](https://www.healthcareitnews.com/news/ai-driven-precision-healthcare-here-what-you-need-know) | [[Healthcare IT News]] | | 10/8/2024 | [**SEQSTER CEO Ardy Arianpour Named to PharmaVoice 100 for Innovation in Life Sciences ...**](https://www.businesswire.com/news/home/20241008712158/en/SEQSTER-CEO-Ardy-Arianpour-Named-to-PharmaVoice-100-for-Innovation-in-Life-Sciences-for-a-Second-Consecutive-Year) | [[Business Wire]] | | 10/8/2024 | [**SEQSTER CEO Ardy Arianpour Named to PharmaVoice 100 for Innovation in Life Sciences for a Second Consecutive Year**](http://www.businesswire.com/news/home/20241008712158/en/SEQSTER-CEO-Ardy-Arianpour-Named-to-PharmaVoice-100-for-Innovation-in-Life-Sciences-for-a-Second-Consecutive-Year/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 10/8/2024 | [**SEQSTER CEO Ardy Arianpour Named to PharmaVoice 100 for Innovation in Life Sciences for a Second Consecutive Year**](http://www.businesswire.com/news/home/20241008712158/en/SEQSTER-CEO-Ardy-Arianpour-Named-to-PharmaVoice-100-for-Innovation-in-Life-Sciences-for-a-Second-Consecutive-Year/?feedref=JjAwJuNHiystnCoBq_hl-Q-tiwWZwkcswR1UZtV7eGe24xL9TZOyQUMS3J72mJlQ7fxFuNFTHSunhvli30RlBNXya2izy9YOgHlBiZQk2LOzmn6JePCpHPCiYGaEx4DL1Rq8pNwkf3AarimpDzQGuQ==) | [[Business Wire]] | | 10/8/2024 | [**SEQSTER CEO Ardy Arianpour Named to PharmaVoice 100 for Innovation in Life Sciences ...**](https://www.morningstar.com/news/business-wire/20241008712158/seqster-ceo-ardy-arianpour-named-to-pharmavoice-100-for-innovation-in-life-sciences-for-a-second-consecutive-year) | [[Morningstar]] | | 10/7/2024 | [**SEQSTER CEO Ardy Arianpour Named to PharmaVoice 100 for Innovation in Life Sciences for a Second Consecutive Year**](https://www.businesswire.com/news/home/20241008712158/en/) | [[Business Wire]] | | 10/4/2024 | [**Hyper-Personalized Medicine Market Research 2024: Size, Trends, Opportunities and Forecast 2020-2024 & 2025-2030 - ResearchAndMarkets.com**](http://www.businesswire.com/news/home/20241004930872/en/Hyper-Personalized-Medicine-Market-Research-2024-Size-Trends-Opportunities-and-Forecast-2020-2024-2025-2030---ResearchAndMarkets.com/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 10/1/2024 | [**Xtalks Announces its Life Science Webinar Calendar for October 2024 - PRWeb**](https://www.prweb.com/releases/xtalks-announces-its-life-science-webinar-calendar-for-october-2024-302263930.html) | [[PRWeb]] | | 7/22/2024 | [**Robert T. Braithwaite, Channing Hamlet and Daniel A. Platt Share Insights on ... - Los Angeles Times**](https://www.latimes.com/business-insights/story/2024-07-22/robert-t-braithwaite-channing-hamlet-and-daniel-a-platt-share-insights-on-the-healthcare-biotech-and-life-sciences-landscape-in-2024) | [[LA Times]] | ## Specialty Overview (Some LLM-derived content — please confirm with above primary sources) ### Key Players - **Labcorp**: A global leader in laboratory services, enhancing genetic testing solutions for oncology and rare diseases. - **Ambry Genetics**: A leader in genetic testing, particularly in hereditary cancer screening, recently acquired by Tempus. - **Genome Medical**: Enhancing the identification of clinical trial patients for ultra-rare diseases using clinical-grade data. - **Myriad Genetics**: A genetic testing company that integrates its MyRisk Hereditary Cancer Test into clinical workflows. - **Genoks**: A Turkish genomics healthcare company providing advanced DNA and RNA sequencing services. - **Invitae**: A company specializing in genetic testing, recently acquired by Labcorp to improve patient care and diagnostic capabilities. - **Myriad Genetics, Inc.**: A company specializing in hereditary cancer testing and pharmacogenomics, focusing on innovation in oncology and women's health. - **BioNexus Gene Lab Corp.**: A company partnering with Shenzhen Rongguang Health Group to enhance cancer screening and precision medicine. - **Epic**: Collaborating with GeneDx to integrate rapid whole genome sequencing into EHR systems. - **Genomics plc**: A company focused on leveraging genetics in healthcare, recently appointed David Thornton as President to enhance operations. - **Texas A&M Health**: An institution partnering with BurstIQ to enhance genomic data governance for clinical genomics registry programs. - **Foundation Medicine**: Offers precision medicine solutions, focusing on genomics and personalized treatment options. - **Guardant Health**: A company specializing in advanced blood and tissue tests for cancer care, emphasizing tumor profiling and ctDNA monitoring. - **BioAI**: A company collaborating with Genomic Testing Cooperative to enhance biomarker discovery and diagnostics using AI. - **LetsGetChecked**: A healthcare company focusing on expanding genomic testing offerings and personalized healthcare solutions. - **Cofactor Genomics**: A clinical-stage diagnostics company focusing on precision medicine by decoding RNA to enhance understanding of health and disease. - **Tempus AI, Inc.**: A leader in genomics and data services, focused on enhancing healthcare through advanced genetic testing and AI insights. - **DNAnexus, Inc.**: A cloud-based platform provider for genomic data analysis, awarded for its contributions to bioinformatics. ### Partnerships and Collaborations - **Labcorp and Ultima Genomics**: Collaborating to utilize UG 100 sequencing technology for clinical applications in whole genome sequencing. - **Labcorp and Invitae**: A partnership aimed at leveraging genetic insights to improve patient care and treatment options. - **DNAnexus and Galatea Bio**: A collaboration aimed at enhancing access to genetic tools for improving health outcomes in Latin American populations. - **Labcorp and Ballad Health**: Strategic collaboration to enhance laboratory services in the Appalachian Highlands. - **Epic and GeneDx**: Collaboration to integrate rapid whole genome sequencing technology into Epic's EHR system. - **Singapore National Precision Medicine Program and Oxford Nanopore Technologies**: Collaborating to sequence 10,000 genomes to enhance understanding of local genetic diversity. - **Genoks and Velsera**: Collaborating to integrate Velsera's Clinical Genomics Workspace into Genoks' cancer diagnostic services. - **BioAI and Genomic Testing Cooperative**: A strategic collaboration to enhance biomarker discovery and diagnostics using multimodal AI. - **BioNexus Gene Lab Corp. and Shenzhen Rongguang Health Group**: Forming a partnership to develop advanced healthcare technologies focusing on cancer detection and personalized healthcare. - **Texas A&M Health and BurstIQ**: Partnering to utilize BurstIQ's LifeGraph management platform for genomic data governance. - **Myriad Genetics and Flatiron Health**: Integrating MyRisk test into Flatiron's OncoEMR platform to enhance cancer care workflows. - **Principle Health Systems and Telos PGX**: Acquisition aimed at enhancing personalized medication solutions through pharmacogenetic testing. - **Guardant Health and MiBA**: A partnership to improve biomarker testing and data analytics for personalized cancer care. - **Mount Sinai and Hasso Plattner Institute**: Collaboration to enhance capabilities in data science and AI, focusing on genomic health and personalized medicine. - **Cofactor Genomics and Dr. Howard McLeod**: Cofactor appointed Dr. McLeod to its Advisory Board to advance precision medicine solutions. - **BIOMAKERS and TOPAZIUM**: Working together to utilize AI and DNA sequencing data to enhance immunotherapy for lung cancer. - **Collaboration Focus**: The conference aims to foster collaboration among pharmaceutical and biotech companies, regulatory authorities, and patient advocacy groups to address challenges in rare disease treatment. - **Digi-Tech Pharma & AI 2025 Conference**: An event emphasizing partnerships between pharmaceutical companies and healthcare providers to enhance research and development through AI. - **Washington University and BJC Health System**: Joint Center for Health AI aimed at streamlining workflows and improving healthcare efficiency. - **Singapore Ministry of Health and Synapxe**: Working together on AI applications to improve healthcare delivery and governance. ### Innovations, Trends, and Initiatives - **Lab Automation Market Growth**: Driven by increased R&D spending and demand for automated laboratories, improving accuracy and efficiency in diagnostics. - **Hyper-personalized Medicine**: An innovative approach tailoring treatments based on genetic makeup and lifestyle, leveraging advancements in genomics. - **Whole-Exome Sequencing (WES)**: Increasingly used in clinical diagnostics for genetic disorders, supported by government reimbursement policies. - **Precision Medicine**: Transforming healthcare by utilizing genetic, environmental, and lifestyle factors for tailored treatments. - **Whole Genome and Exome Sequencing Market**: Projected to grow significantly, driven by demand for personalized medicine and advancements in genetic testing. - **Next-Generation Sequencing (NGS)**: Technological advancements in DNA sequencing improving accuracy and efficiency, facilitating personalized medicine. - **Generative AI in Scientific Research**: Enhancing research efficiency and collaboration, particularly in drug discovery and genomics. - **DNA Synthesis Market Growth**: Driven by advancements in genomics and personalized medicine, with significant demand for oligonucleotide and gene synthesis. - **Liquid Biopsy Tests**: Guardant Health's focus on transforming cancer care through advanced blood tests that monitor tumor dynamics. - **AI-Driven Genomic Analysis**: Utilization of AI to enhance genomic data analysis, improving patient outcomes and operational efficiency in healthcare. - **Precision Health Data Cloud**: DNAnexus' platform that facilitates the analysis of diverse datasets to improve genetic research. - **Generative AI in Life Sciences**: Recognized for its potential in research and development, though adoption remains slow due to various challenges. - **Next-Generation Sequencing (NGS) Services Market**: Projected growth at a CAGR of 21.25% from 2024 to 2031, driven by advancements in precision medicine. - **Health Expression Models (HEMs)**: Cofactor Genomics' patented models that decode RNA data to provide insights into health and disease. - **AI in Biomarker Discovery**: The use of AI technologies to enhance the development of genomic biomarker screening algorithms and assays. - **AI and Machine Learning in NGS**: Integration of AI in sequencing data analysis enhancing efficiency and accessibility of NGS services. - **Microfluidics Market Expansion**: Advancements in microfluidic devices are revolutionizing healthcare diagnostics with faster and more accurate testing methods. - **AI in Healthcare**: GE HealthCare's AI Innovation Lab aims to enhance clinical decision-making and patient outcomes through AI integration. - **Investment Trends**: The biotech sector is experiencing increased R&D spending in lucrative areas such as rare diseases, driven by new drug approvals and pipeline updates. - **Emerging Therapies**: The conference will highlight updates on regulatory developments and innovative drug discovery strategies aimed at improving outcomes for individuals with rare conditions. ### Challenges and Concerns - **Data Privacy**: Concerns regarding the handling of personal data in genetic testing and healthcare applications. - **Data Privacy and Security**: Concerns regarding patient privacy and informed consent in genetic testing and data sharing among clinicians. - **High Costs of Precision Medicine**: The financial burden associated with advanced genetic testing and personalized treatments. - **High Equipment Costs in Lab Automation**: Challenges related to the high costs of lab automation equipment and infrastructure limitations in developing countries. - **Market Sentiment**: Labcorp's stock decline following the announcement of its acquisition of assets from Invitae, indicating investor concerns. - **Need for Interdisciplinary Collaboration**: Challenges in integrating various healthcare professionals and researchers in the precision medicine landscape. - **Regulatory Challenges**: The heavily regulated nature of the biopharma industry poses barriers to the adoption of generative AI. - **Ethical and Regulatory Challenges**: Navigating the complexities of implementing AI in precision medicine while ensuring compliance with regulations. - **Data Fragmentation**: Hinders advancements in patient care and clinical research, obstructing personalized treatment interventions. - **High Implementation Costs**: The financial burden associated with adopting precision medicine software and AI technologies, particularly for smaller healthcare institutions. - **Market Dynamics**: The biotech sector is perceived as riskier than large-cap pharma due to its dynamic nature and challenges smaller companies face in reaching targeted populations without sufficient funds. - **Patient Awareness**: General lack of understanding among patients regarding HIPAA regulations and consent for data use. - **Regulatory Hurdles**: Regulatory challenges and public skepticism may impede the widespread adoption of innovative therapies in the market. - **Interoperability Issues**: Clinics struggle with limited features compared to larger hospital systems, affecting patient management. - **Data Security and Ethical Considerations**: Concerns about the security and potential re-identification of de-identified patient data in AI applications. - **Security and Privacy**: Robust security measures are essential to ensure the integrity of patient data in healthcare technology. - **Patient Consent Issues**: Patients often face challenges in understanding consent forms, raising concerns about the coercive nature of consent in healthcare. ## Related Topics [[Laboratory Genomics]]; [[Clinical Genetics]]; [[Medical Genetics]]; [[Biochemical Genetics]]; [[Genetic Testing]]; [[Clinical Genomics]]; [[Clinical Biochemical Genetics]]; [[Medical Biochemical Genetics]]; [[Genetic Pathology]]